Free Trial

11,650 Shares in Chemed Co. (NYSE:CHE) Acquired by Trexquant Investment LP

Chemed logo with Medical background
Remove Ads

Trexquant Investment LP purchased a new stake in Chemed Co. (NYSE:CHE - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 11,650 shares of the company's stock, valued at approximately $6,172,000. Trexquant Investment LP owned approximately 0.08% of Chemed as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of CHE. Headlands Technologies LLC acquired a new stake in shares of Chemed in the fourth quarter valued at approximately $230,000. Geode Capital Management LLC increased its position in shares of Chemed by 1.5% in the 4th quarter. Geode Capital Management LLC now owns 340,409 shares of the company's stock valued at $180,654,000 after buying an additional 4,966 shares in the last quarter. Franklin Resources Inc. lifted its holdings in shares of Chemed by 18.6% during the 4th quarter. Franklin Resources Inc. now owns 10,436 shares of the company's stock valued at $5,529,000 after purchasing an additional 1,636 shares in the last quarter. B. Metzler seel. Sohn & Co. AG raised its holdings in Chemed by 8.7% during the 4th quarter. B. Metzler seel. Sohn & Co. AG now owns 560 shares of the company's stock worth $297,000 after buying an additional 45 shares during the period. Finally, Prevail Innovative Wealth Advisors LLC boosted its holdings in shares of Chemed by 75.0% in the fourth quarter. Prevail Innovative Wealth Advisors LLC now owns 9,723 shares of the company's stock valued at $5,151,000 after buying an additional 4,166 shares during the period. 95.85% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

CHE has been the topic of a number of recent research reports. Royal Bank of Canada lifted their target price on Chemed from $633.00 to $667.00 and gave the company an "outperform" rating in a research report on Friday, March 14th. StockNews.com raised shares of Chemed from a "hold" rating to a "buy" rating in a research note on Friday, March 7th.

Remove Ads

Check Out Our Latest Stock Report on Chemed

Insiders Place Their Bets

In other news, CEO Kevin J. Mcnamara sold 1,000 shares of Chemed stock in a transaction that occurred on Monday, March 31st. The shares were sold at an average price of $615.33, for a total value of $615,330.00. Following the completion of the sale, the chief executive officer now directly owns 101,679 shares in the company, valued at approximately $62,566,139.07. The trade was a 0.97 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 3.32% of the company's stock.

Chemed Price Performance

NYSE CHE traded down $5.96 during trading on Thursday, reaching $582.09. 27,693 shares of the company's stock were exchanged, compared to its average volume of 96,489. Chemed Co. has a fifty-two week low of $512.12 and a fifty-two week high of $627.12. The stock has a market capitalization of $8.52 billion, a P/E ratio of 29.41, a PEG ratio of 2.15 and a beta of 0.49. The business has a 50 day moving average price of $581.75 and a 200-day moving average price of $567.98.

Chemed Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Shareholders of record on Monday, February 24th were issued a $0.50 dividend. The ex-dividend date was Monday, February 24th. This represents a $2.00 annualized dividend and a dividend yield of 0.34%. Chemed's dividend payout ratio is currently 10.05%.

Chemed Company Profile

(Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Further Reading

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Should You Invest $1,000 in Chemed Right Now?

Before you consider Chemed, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.

While Chemed currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

5 International Stocks to Escape U.S. Market Volatility

5 International Stocks to Escape U.S. Market Volatility

MarketBeat’s Chris Markoch shares 5 international stock picks that could offer protection—and potential opportunity—amid the current market uncertainty.

Related Videos

3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
3 AI Stocks to Watch After NVIDIA’s Dip

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads